Suppr超能文献

肾素-血管紧张素系统阻滞剂联合治疗:氨氯地平会取代氢氯噻嗪吗?

Combination therapy with renin-angiotensin system blockers: will amlodipine replace hydrochlorothiazide?

作者信息

Tejada Thor, Fornoni Alessia, Lenz Oliver, Materson Barry J

机构信息

Division of Nephrology and Hypertension, Department of Medicine, Miller School of Medicine, University of Miami OPPRP (D-54), PO Box 016960, Miami, FL 33101, USA.

出版信息

Curr Hypertens Rep. 2007 Aug;9(4):284-90. doi: 10.1007/s11906-007-0052-0.

Abstract

Amlodipine is a highly effective and safe antihypertensive dihydropyridine calcium channel blocker. It is even more effective when used in combination with other antihypertensive medications, including hydrochlorothiazide. When antihypertensive calcium channel blockers were first introduced, evidence in the laboratory that they had some natriuretic properties was adduced to suggest that they would be "the diuretics of the 1990s." This turned out not to be the case. Because of its clinical efficacy, amlodipine is frequently used in fixed-dose combination products, but it is not likely to replace hydrochlorothiazide.

摘要

氨氯地平是一种高效且安全的抗高血压二氢吡啶类钙通道阻滞剂。与包括氢氯噻嗪在内的其他抗高血压药物联合使用时,它的效果更佳。当抗高血压钙通道阻滞剂首次被引入时,实验室证据表明它们具有一定的利钠特性,据此有人提出它们将成为“20世纪90年代的利尿剂”。但事实并非如此。由于其临床疗效,氨氯地平经常被用于固定剂量复方制剂中,但它不太可能取代氢氯噻嗪。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验